Plant-derived natural compounds as promising anticancer agents in hematological malignancies

The latest treatments have improved outcomes for patients with hematological malignancies, but relapse, treatment resistance and particularly side effects still remain as common limitations of these treatments. Given the disadvantages existing conventional therapeutic methods, developing more effective drugs less toxicity is paramount importance. Medicinal herbs historically proven their worth a pool potential agents leukemia lymphoma, today they represent rich source recognition new drug leads. role positive synergistic plant-derived natural products chemotherapeutic also considered one rational reasons paying attention to medicinal plants in recent chemoprevention investigations. Noteworthy, targeted delivery via incorporation nanoparticles or antibodies would be major step improve bioavailability then increase effects. In this study, we reviewed approved and/or under investigation malignancies.